WAT · NYQ S&P 500

Waters Corporation

Healthcare · Diagnostics & Research

$475.52 −$1.18 (−0.25%) today

Closing price on Nov 10, 2026 · Source: Yahoo Finance

Consensus of 24 analysts

Buy

Median price target $504.00 +6.0%

Open: $470.00
Day range: 467.72 – $480.05
52-week range: 282.77 – $482.28
Volume: 889,323
Market cap: $46,689M
P/E (TTM): 199.0x
EPS (TTM): $2.39
EPS est. 2026: $14.67
P/E est. 2026: 32.4x
Dividend yield: n/a
Beta: 1.15
Payout: 0%

Waters financials

Q2 2026 results, quarter ended Jun 30, 2026

Metric	Q2 2026	1-year change
Total revenue	$1,645M	+113.4%
Net income	−$136M	−192.5%
Earnings per share	−$1.39	−192.8%
Net margin	−8.3%	−27.3 pp
Free cash flow	$153M	+750.0%
Debt / equity	0.36	−49.6%

Revenue and net income ($M)

Total revenueNet income

Quarter	Total revenue	Net income
Q2 2025	$771M	$147M
Q3 2025	$800M	$149M
Q4 2025	$932M	$225M
Q1 2026	$1,267M	−$72M
Q2 2026	$1,645M	−$136M

Waters earnings per share (EPS)

Consensus estimates

Period	EPS est.	1-year change
Current quarterQ4 2026 · Analysts: 20	$4.6544.60 – 4.76	+2.7%$4.530
Next quarterQ1 2027 · Analysts: 13	$3.2053.00 – 3.67	+18.7%$2.700
Current year2026 · Analysts: 23	$14.66714.61 – 14.80	+11.7%$13.130
Next year2027 · Analysts: 24	$16.52816.23 – 16.92	+12.7%$14.667

Forward P/E: 32.4x (2026) and 28.8x (2027) at the current price.

Actual and estimated EPS ($)

Actual EPSEstimated EPS

Quarter	Actual EPS	Estimated EPS
Q2 2025	$1.497	—
Q3 2025	$2.500	—
Q4 2025	$4.530	$4.509
Q1 2026	$2.700	$2.308
Q2 2026	$3.050	$3.008
Q3 2026	$4.100	$3.998
Q4 2026	—	$4.654
Q1 2027	—	$3.205

Year	Actual EPS	Estimated EPS
2022	$11.730	—
2023	$10.840	—
2024	$10.710	—
2025	$10.760	—
2026	—	$14.667
2027	—	$16.528

EPS trend

Quarter	EPS	YoY change
Q1 2027Estimated	$3.205	+18.7%
Q4 2026Estimated	$4.654	+2.7%
Q3 2026	$4.100est. $3.998 · surprise +2.6%	+64.0%
Q2 2026	$3.050est. $3.008 · surprise +1.4%	+103.7%
Q1 2026	$2.700est. $2.308 · surprise +17.0%	n/a
Q4 2025	$4.530est. $4.509 · surprise +0.5%	n/a
Q3 2025	$2.500	n/a
Q2 2025	$1.497	n/a

Year	EPS	Annual change
2027Estimated	$16.528	+12.7%
2026Estimated	$14.667	+36.3%
2025	$10.760	+0.5%
2024	$10.710	−1.2%
2023	$10.840	−7.6%
2022	$11.730	n/a

Normalised EPS according to the analyst consensus collected by Yahoo Finance; it may differ from the reported EPS in the results table.

Waters dividend

Waters has not paid dividends in recent years.

Waters forecasts

24 analyst ratings

Buy75% Hold21% Sell4%

Consensus: Buy · 18 buy, 5 hold, 1 sell

1-year price forecast

Share price Price target (high, median, low)

12-month price targets
Target	Price	Upside
High	$550.00	+15.7%
Median	$504.00	+6.0%
Low	$387.00	−18.6%

Monthly close (last 12 months)
Date	Close
Nov 28, 2025	$403.42
Dec 31, 2025	$379.83
Jan 30, 2026	$370.72
Feb 27, 2026	$319.38
Mar 31, 2026	$297.80
Apr 30, 2026	$309.23
May 29, 2026	$383.57
Jun 30, 2026	$375.04
Jul 31, 2026	$377.31
Aug 31, 2026	$414.63
Sep 30, 2026	$439.39
Oct 30, 2026	$462.72
Nov 10, 2026	$475.52

Waters peers

Ticker	Company	Market cap ($M)	P/E	Price ($)	1-day change	52-week range
WAT	Waters	46,689	199.0x	475.52	−0.25%	282.77482.28
TMO	Thermo Fisher Scientific	266,105	37.9x	718.20	−0.48%	435.27723.08
DHR	Danaher	166,111	39.1x	236.11	+0.42%	160.93242.80
IDXX	Idexx Laboratories	54,886	46.9x	696.64	−1.42%	500.61769.98
A	Agilent Technologies	50,150	35.1x	177.88	−1.27%	108.35182.99
IQV	IQVIA	45,345	33.5x	275.15	−1.32%	154.50284.50